Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicVAX and Varenicline for Smoking Cessation
NCT00995033Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2009
- Primary completion
- Sep 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NicVAX in nicotine dependence, sponsored by Maastricht University Medical Center+. Started Oct 2009; status: completed.
02
Drugs
NicVAX
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00995033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995033.